
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression
Artem Nemudryi, Anna Nemudraia, Tanner Wiegand, et al.
Cell Reports (2021) Vol. 35, Iss. 9, pp. 109197-109197
Open Access | Times Cited: 79
Artem Nemudryi, Anna Nemudraia, Tanner Wiegand, et al.
Cell Reports (2021) Vol. 35, Iss. 9, pp. 109197-109197
Open Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 166
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 166
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression
Najla Arshad, Maudry Laurent-Rolle, Wesam S. Ahmed, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 82
Najla Arshad, Maudry Laurent-Rolle, Wesam S. Ahmed, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 82
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 72
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 72
Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic
Andrew Santiago‐Frangos, L Hall, Anna Nemudraia, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 6, pp. 100319-100319
Open Access | Times Cited: 75
Andrew Santiago‐Frangos, L Hall, Anna Nemudraia, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 6, pp. 100319-100319
Open Access | Times Cited: 75
SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes
Paulina Pawlica, Therese A. Yario, Sylvia S. White, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 52
Open Access | Times Cited: 66
Paulina Pawlica, Therese A. Yario, Sylvia S. White, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 52
Open Access | Times Cited: 66
Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection*
Carolina Chiale, Trever T. Greene, Elina I. Zúñiga
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 12-24
Open Access | Times Cited: 47
Carolina Chiale, Trever T. Greene, Elina I. Zúñiga
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 12-24
Open Access | Times Cited: 47
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
Li Wang, Markus H. Kainulainen, Nannan Jiang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Li Wang, Markus H. Kainulainen, Nannan Jiang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity
MST Monira Begum, Kimiko Ichihara, Otowa Takahashi, et al.
Frontiers in Virology (2024) Vol. 4
Open Access | Times Cited: 11
MST Monira Begum, Kimiko Ichihara, Otowa Takahashi, et al.
Frontiers in Virology (2024) Vol. 4
Open Access | Times Cited: 11
The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia
Galya V. Klink, Ksenia R. Safina, Elena Nabieva, et al.
Virus Evolution (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Galya V. Klink, Ksenia R. Safina, Elena Nabieva, et al.
Virus Evolution (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand
Lauren Jelley, Jordan Douglas, Xiaoyun Ren, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Lauren Jelley, Jordan Douglas, Xiaoyun Ren, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28
A comprehensive review of current insights into the virulence factors of SARS-CoV-2
Yi Wang, Bingqing Xia, Zhaobing Gao
Journal of Virology (2025)
Open Access
Yi Wang, Bingqing Xia, Zhaobing Gao
Journal of Virology (2025)
Open Access
Dissecting the COVID ‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS ‐CoV ‐2 Structural Proteins
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access
Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene
Alyssa T. Pyke, Neelima Nair, Andrew F. van den Hurk, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1087-1087
Open Access | Times Cited: 38
Alyssa T. Pyke, Neelima Nair, Andrew F. van den Hurk, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1087-1087
Open Access | Times Cited: 38
Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins
Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6394-6394
Open Access | Times Cited: 25
Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6394-6394
Open Access | Times Cited: 25
The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron
Tanner Wiegand, Artem Nemudryi, Anna Nemudraia, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2009-2009
Open Access | Times Cited: 25
Tanner Wiegand, Artem Nemudryi, Anna Nemudraia, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2009-2009
Open Access | Times Cited: 25
Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b
Tránsito García‐García, Raúl Fernández‐Rodríguez, Natalia Redondo, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105444-105444
Open Access | Times Cited: 24
Tránsito García‐García, Raúl Fernández‐Rodríguez, Natalia Redondo, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105444-105444
Open Access | Times Cited: 24
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression
Najla Arshad, Maudry Laurent-Rolle, Wesam S. Ahmed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 21
Najla Arshad, Maudry Laurent-Rolle, Wesam S. Ahmed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 21
Translational Control of COVID-19 and Its Therapeutic Implication
Dejiu Zhang, Lei Zhu, Yin Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Dejiu Zhang, Lei Zhu, Yin Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics
Izumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 10
Izumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 10
Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program
Ana Jung, Lindsay Droit, Binita Febles, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 3
Ana Jung, Lindsay Droit, Binita Febles, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 3
Enhancing SARS-CoV-2 Lineage Surveillance through the Integration of a Simple and Direct qPCR-Based Protocol Adaptation with Established Machine Learning Algorithms
Cleber Furtado Aksenen, DANIELE VIEIRA FERREIRA, Pedro Miguel Carneiro Jerônimo, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 46, pp. 18537-18544
Open Access | Times Cited: 3
Cleber Furtado Aksenen, DANIELE VIEIRA FERREIRA, Pedro Miguel Carneiro Jerônimo, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 46, pp. 18537-18544
Open Access | Times Cited: 3
The emergence, spread and vanishing of a French SARS‐CoV‐2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule
Philippe Colson, Philippe Gautret, Jérémy Delerce, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 17
Philippe Colson, Philippe Gautret, Jérémy Delerce, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 17
GRP78, a Novel Host Factor for SARS-CoV-2: The Emerging Roles in COVID-19 Related to Metabolic Risk Factors
Jihoon Shin, Shinichiro Toyoda, Atsunori Fukuhara, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1995-1995
Open Access | Times Cited: 16
Jihoon Shin, Shinichiro Toyoda, Atsunori Fukuhara, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1995-1995
Open Access | Times Cited: 16
Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
Jesús Hurtado-Tamayo, Ricardo Requena-Platek, Luis Enjuanes, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 9
Jesús Hurtado-Tamayo, Ricardo Requena-Platek, Luis Enjuanes, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 9